DE69409969T2 - Salze der mehrfach ungesättigten fettsäuren und diese enthaltende pharmazeutischen zusammensetzungen - Google Patents

Salze der mehrfach ungesättigten fettsäuren und diese enthaltende pharmazeutischen zusammensetzungen

Info

Publication number
DE69409969T2
DE69409969T2 DE69409969T DE69409969T DE69409969T2 DE 69409969 T2 DE69409969 T2 DE 69409969T2 DE 69409969 T DE69409969 T DE 69409969T DE 69409969 T DE69409969 T DE 69409969T DE 69409969 T2 DE69409969 T2 DE 69409969T2
Authority
DE
Germany
Prior art keywords
fatty acid
pharmaceutical compositions
compositions containing
unsaturated fatty
acid salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69409969T
Other languages
English (en)
Other versions
DE69409969D1 (de
Inventor
Tiberio Bruzzese
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Prospa NV
Original Assignee
Prospa NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prospa NV filed Critical Prospa NV
Publication of DE69409969D1 publication Critical patent/DE69409969D1/de
Application granted granted Critical
Publication of DE69409969T2 publication Critical patent/DE69409969T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
DE69409969T 1993-12-14 1994-11-28 Salze der mehrfach ungesättigten fettsäuren und diese enthaltende pharmazeutischen zusammensetzungen Expired - Lifetime DE69409969T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT93MI002612A IT1264987B1 (it) 1993-12-14 1993-12-14 Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
PCT/EP1994/003943 WO1995016661A1 (en) 1993-12-14 1994-11-28 Salts of a polyunsaturated fatty acid and pharmaceutical formulations containing them

Publications (2)

Publication Number Publication Date
DE69409969D1 DE69409969D1 (de) 1998-06-04
DE69409969T2 true DE69409969T2 (de) 1998-12-10

Family

ID=11367322

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69409969T Expired - Lifetime DE69409969T2 (de) 1993-12-14 1994-11-28 Salze der mehrfach ungesättigten fettsäuren und diese enthaltende pharmazeutischen zusammensetzungen

Country Status (8)

Country Link
US (1) US5750572A (de)
EP (1) EP0734373B1 (de)
JP (1) JPH09508619A (de)
AU (1) AU1241295A (de)
DE (1) DE69409969T2 (de)
ES (1) ES2117390T3 (de)
IT (1) IT1264987B1 (de)
WO (1) WO1995016661A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102022003441A1 (de) 2022-09-17 2024-03-28 Jutta Ibrahim Nahrungsergänzungsmittel Omega3 und essentielle Aminosäure(n)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107499A (en) * 1988-02-26 2000-08-22 Neuromedica, Inc. Dopamine analog amide
AUPM906594A0 (en) * 1994-10-26 1994-11-17 Peptide Technology Limited Synthetic polyunsaturated fatty acid analogues
US6576636B2 (en) 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US5955459A (en) * 1997-11-26 1999-09-21 Neuromedica, Inc. Fatty acid-antipsychotic compositions and uses thereof
US6197764B1 (en) 1997-11-26 2001-03-06 Protarga, Inc. Clozapine compositions and uses thereof
FR2781371B1 (fr) 1998-07-21 2001-04-27 Oreal Composition cosmetique aqueuse transparente a une seule phase
US7235583B1 (en) * 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
WO2002076404A2 (en) * 2001-03-23 2002-10-03 Protarga, Inc. Fatty alcohol drug conjugates
JP2005500988A (ja) 2001-03-23 2005-01-13 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド 脂肪族アミン薬物複合体
US8729124B2 (en) 2002-03-05 2014-05-20 Pronova Biopharma Norge As Use of EPA and DHA in secondary prevention
GB0210212D0 (en) * 2002-05-03 2002-06-12 Univ Southampton Effects of dietary N-3 and N-6 pufa intake on atheromatous plaque stability
JP2003261456A (ja) * 2002-03-08 2003-09-16 Howaizu:Kk 脳の老化予防剤
US20050130937A1 (en) * 2003-10-22 2005-06-16 Enzymotec Ltd. Lipids containing omega-3 and omega-6 fatty acids
US8052992B2 (en) * 2003-10-22 2011-11-08 Enzymotec Ltd. Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions
US7935365B2 (en) 2003-10-22 2011-05-03 Enzymotec, Ltd. Glycerophospholipids for the improvement of cognitive functions
HU227588B1 (hu) * 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
ITMI20072142A1 (it) * 2007-11-08 2009-05-09 Yervant Zarmanian Composizioni farmaceutiche contenenti statine e derivati di acidi grassi omega-3
JP5979816B2 (ja) 2008-01-04 2016-08-31 ネステク ソシエテ アノニム 不飽和脂肪酸及び酸化窒素放出化合物を含む組成物、並びに認知機能及び関連の機能を高めるためのそれらの使用
US20110237670A1 (en) 2008-12-12 2011-09-29 Daniel Klamer Improvement of normal cognitive function
ES2685703T3 (es) 2012-01-06 2018-10-10 Omthera Pharmaceuticals Inc. Composiciones enriquecidas en DPA de ácidos grasos omega-3 poliinsaturados en forma de ácido libre
CA2951923A1 (en) * 2014-06-18 2015-12-23 Thetis Pharmaceuticals Llc Mineral amino-acid complexes of active agents
DK3236783T3 (da) * 2014-12-23 2020-04-27 Evonik Operations Gmbh Fremgangsmåde til forøgelse af stabiliteten af en sammensætning, der omfatter flerumættede omega-6-fedtsyrer
MX2017007846A (es) 2014-12-23 2017-09-19 Evonik Degussa Gmbh Proceso para aumentar la estabilidad de una composicion que comprende acidos grasos omega-3 poliinsaturados.
FR3031451B1 (fr) * 2015-01-13 2018-03-23 Greentech Sel d'un triglyceride, preparation et utilisations
EP3248467A1 (de) * 2016-05-25 2017-11-29 Evonik Technochemie GmbH Verfahren zur herstellung einer zusammensetzung enthaltend omega-3-fettsäure-l-lysin-salze
WO2017202942A1 (en) * 2016-05-25 2017-11-30 Evonik Technochemie Gmbh Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
US10130719B2 (en) 2016-06-03 2018-11-20 Thetis Pharmaceuticals Llc Compositions and methods relating to salts of specialized pro-resolving mediators
EP3648748A1 (de) 2017-07-06 2020-05-13 Evonik Operations GmbH Enterische beschichtete feste darreichungsform mit omega-3-fettsäure-aminosäure-salzen
CN111032032B (zh) * 2017-08-15 2024-01-02 赢创运营有限公司 具有高活性成分含量的ω-3脂肪酸氨基酸盐的片剂
WO2019093708A1 (ko) * 2017-11-08 2019-05-16 김승수 악취 억제형 불포화오일 및 아르기닌 함유 조성물의 제조 방법
KR102172036B1 (ko) * 2017-11-08 2020-10-30 주식회사 오스테온 악취 억제형 불포화오일 및 아르기닌 함유 조성물의 제조 방법
EP3886908A1 (de) * 2018-11-30 2021-10-06 Evonik Operations GmbH Präparat mit einer dispersion von phospholipiden und fettsäuresalzen
US20220233487A1 (en) 2019-05-06 2022-07-28 Evonik Operations Gmbh Preparation for use in weight management comprising omega-3 fatty acid salts and basic amino acids
BR112022002135A2 (pt) 2019-08-08 2022-04-19 Evonik Operations Gmbh Método de preparação de uma forma de dosagem sólida e um lubrificante
BR112022002129A2 (pt) 2019-08-08 2022-04-19 Evonik Operations Gmbh Processo a jusante para a produção de sais de ácidos graxos poli-insaturados
EP4009960A1 (de) 2019-08-08 2022-06-15 Evonik Operations GmbH Verfahren zur herstellung einer festen darreichungsform und eines bindemittels
EP3804699A1 (de) 2019-10-10 2021-04-14 Evonik Operations GmbH Verfahren zur herstellung einer festen darreichungsform und eines bindemittels
EP4009961A1 (de) * 2019-08-08 2022-06-15 Evonik Operations GmbH Löslichkeitsverbesserung von schwerlöslichen wirkstoffen
IL294990A (en) * 2020-01-30 2022-09-01 Silicycle Inc A process for preparing a solid form of basic amino acid salts of polyunsaturated fatty acids
WO2021197971A1 (en) 2020-04-01 2021-10-07 Evonik Operations Gmbh Preparation for use as antioxidant
EP4125437A1 (de) 2020-04-01 2023-02-08 Evonik Operations GmbH Zubereitung zur verwendung als vasorelaxans

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7405325A (de) * 1973-04-25 1974-10-29
HU209973B (en) * 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102022003441A1 (de) 2022-09-17 2024-03-28 Jutta Ibrahim Nahrungsergänzungsmittel Omega3 und essentielle Aminosäure(n)

Also Published As

Publication number Publication date
ES2117390T3 (es) 1998-08-01
AU1241295A (en) 1995-07-03
EP0734373A1 (de) 1996-10-02
US5750572A (en) 1998-05-12
IT1264987B1 (it) 1996-10-17
ITMI932612A0 (it) 1993-12-14
DE69409969D1 (de) 1998-06-04
ITMI932612A1 (it) 1995-06-14
WO1995016661A1 (en) 1995-06-22
JPH09508619A (ja) 1997-09-02
EP0734373B1 (de) 1998-04-29

Similar Documents

Publication Publication Date Title
DE69409969T2 (de) Salze der mehrfach ungesättigten fettsäuren und diese enthaltende pharmazeutischen zusammensetzungen
DE69328492D1 (de) Fettsäure-derivate und diese enthaltende pharmazeutische präparationen
NO940288L (no) Formuleringer inneholdende umettede fettsyrer
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
NO940277L (no) Triglycerider og blandinger av slike
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
DE69015842D1 (de) Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen.
ITBO910113A0 (it) Formulazioni farmaceutiche per uso orale castroresistenti contenenti acidi biliari
DE69512929T2 (de) Salze von aminoalkoholen und diese enthaltende pharmazeutische zusammensetzungen
ITTO920303A0 (it) "composizione farmaceutica antiinfiammatoria"
MX9200146A (es) Composiciones farmaceuticas deglutibles
PT925273E (pt) Composicoes farmaceuticas contendo acidos 4-oxobutanoicos
NZ227669A (en) Amino acid glycerides and pharmaceutical compositions thereof
NZ215587A (en) 3-oxoandrost-4-ene-17beta-carboxylic acid ester derivatives and pharmaceutical compositions
ITMI950961A0 (it) Composizioni farmaceutiche contenenti gemfibrozil
FI952377A0 (fi) Farmaseuttisia ibuprofeenikoostumuksia
ITMI913510A1 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
NZ238848A (en) Sulphur-substituted mevinic acid compounds and pharmaceutical compositions
FR2607005B1 (fr) Compositions pharmaceutiques contenant de l'acide ursodesoxycholique
IL94937A0 (en) Pharmaceutical compositions containing acrylic acid derivatives
DE69111530T2 (de) Pyridincarbonsäure-Amid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
IT8620737A1 (it) Composizioni farmaceutiche contenenti levodopa metil estere, loro procedimento di preparazione e relative applicazioni terapeutiche
IT8719221A0 (it) Composizioni farmaceutiche contenenti levodopa metil estere, loro prodecimento di preparazione e relative applicazioni terapeutiche.
FR2608597B1 (fr) Compositions pharmaceutiques contenant de l'acetylsalicylate de lysine
IL93184A0 (en) Pharmaceutical compositions containing fatty acids and methods for the use thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition